This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Covisint Publishes Direct Messaging Toolkit For Healthcare, Clarifies Misconceptions And Outlines Benefits

DETROIT, July 9, 2013 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, today announced that it has published a toolkit offering a comprehensive set of resources that outline the benefits of and uses for Direct messaging for key healthcare stakeholders. Collectively, these items answer common questions, dispel misconceptions and outline how Direct messaging makes healthcare providers eligible for federal monies and Meaningful Use Stage II requirements.
Compuware Logo
Covisint Logo

Specifically, the Covisint toolkit on Direct includes a:
  • whitepaper addressing whether Direct replaces HIEs, while also examining redundancies and HIPAA requirements ( The Direct Evolution; Why It Will Change How You Communicate);
  • guidebook on workflow integration and internal champions ( Steps to Direct Success); and,
  • research on why to adopt Direct ( Why You Need to Invest Today).

Direct messaging has received a large boost recently in two ways since it:

1. is federally driven -- the Office of the National Coordinator (ONC) and the Centers for Medicare and Medicaid (CMS) are increasingly requiring Direct to be part of the ecosystems of state Medicaid agencies and health information exchange (HIE) projects; and,

2. advances Meaningful Use Stage II qualification -- in order to continue receiving Meaningful Use funds and incentives, individual providers and hospitals are required to use a Direct solution.

"The momentum behind Direct is nearing the tipping point," said John Stanley, Principal, Impact Advisors. "Most healthcare providers and facilities are aware of Direct and are preparing a deployment plan."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs